EODData

MEMBERSHIP REGISTER LOG IN

SHG, 688319: Chengdu Olymvax Biopharmaceuticals Inc. A

03 Sep 2025
LAST:

28.74

CHANGE:
 0.13		OPEN:
28.81		HIGH:
29.36		ASK:
0.00		VOLUME:
6.53M
CHG(%):
0.45		PREV:
28.87		LOW:
28.54		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Sep 2528.8129.3628.5428.746.53M
02 Sep 2529.9830.9828.7228.8711.32M
01 Sep 2529.6930.6928.7829.9713.81M
29 Aug 2529.7031.3029.5029.7811.79M
28 Aug 2529.1429.6027.9129.289.63M
27 Aug 2530.2630.8129.0029.1710.08M
26 Aug 2532.4533.0630.2030.2513.92M
25 Aug 2531.7833.1931.1532.679.83M
22 Aug 2532.7034.2032.2133.1711.66M
21 Aug 2533.9034.6832.6232.7013.55M

COMPANY PROFILE

Name:Chengdu Olymvax Biopharmaceuticals Inc. A
About:Chengdu Olymvax Biopharmaceuticals Inc. engages in the research and development, production, and sales of vaccines for human use. It offers adsorbed tetanus vaccine; Hib conjugate vaccine; Group A streptococcus vaccine; and AC conjugate vaccine. The company also provides vaccines for haemophilus influenzae type b; group A and C meningococcal; and staphylococcus aureus, which is in Phase 3 clinical trial. In addition, it engages in technology promotion and application services business; biotechnology, R&D, and consulting. The company was founded in 2009 and is based in Chengdu, China.
Sector:Healthcare
Industry:Biotechnology
Address:No. 99 Tianxin Road, Chengdu, China, 611731
Website:https://www.olymvax.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:331.70
Price to Book:14.64
Price to Sales:22.24
EBITDA:72.93M
Shares:405.93M
Market Cap:11.667B

TECHNICAL INDICATORS

MA5:29.33
MA10:30.46
MA20:27.56
MA50:22.02
MA100:19.07
MA200:15.67
STO14:44.43
RSI14:63.59
WPR14:-48.26
MTM14:4.75
ROC14:0.20
ATR:2.47
Week High:31.30
Week Low:27.91
Month High:34.68
Month Low:19.99
Year High:34.68
Year Low:8.11